Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Proquad (Merck and Co) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F

globenewswire.com
MRK Merck & Co. Inc. is innovating ProQuad administration with intramuscular delivery, receiving FDA approval for its MMRV vaccines. This, combined with the growing ProQuad market driven by increased vaccination needs and government support, suggests a positive outlook for the company.

Proquad (Merck and Co) Market Research Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts, 2020-2025, 2025-2030F, 2035F Dublin, March 09, 2026 (GLOBE NEWSWIRE) -- The "Proquad Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.

The ProQuad market is experiencing robust growth, fueled by a multitude of factors. Historically, expansion of childhood vaccination programs and enhanced public health awareness have led to an increased demand for combination vaccines like ProQuad. Government funding and improved pediatric healthcare infrastructures have played crucial roles in this upward trend.

Looking ahead, the ProQuad market is poised for continued expansion. Key drivers include the global push to meet vaccination coverage targets and heightened investments in next-generation vaccine development. Public-private vaccination partnerships and enhanced distribution logistics further bolster this growth trajectory. Emphasizing immunization compliance, authorities are increasingly adopting combination vaccines, optimizing cold chain logistics, and improving vaccine safety systems.

The rising incidence of measles and chickenpox significantly influences the ProQuad market. Declining vaccination rates, misinformation, and global travel have contributed to recent outbreaks of these preventable diseases. ProQuad, a combination MMRV vaccine, addresses these concerns by providing immunity with a single dose, thereby reducing infection rates and preventing disease complications.

Escalating healthcare expenditures are another supporting factor for the ProQuad market. Increased chronic disease prevalence, an aging population, and advancements in medical technology drive these expenses, which in turn fund immunization programs and infrastructure development. For instance, UK healthcare expenditure reached approximately $362 billion, reflecting a notable increase, further supporting ProQuad market expansion.

Key industry players like Merck & Co. Inc. are innovating ProQuad administration options by incorporating intramuscular delivery to enhance vaccine administration efficiency. This flexibility is evidenced by recent FDA approvals, allowing the IM administration of Merck's MMRV vaccines, streamlining processes for healthcare professionals.

Regionally, North America holds a significant market position, whereas Asia-Pacific is anticipated to witness rapid growth during the forecast period. Nevertheless, specific challenges such as tariffs on imported biological raw materials pose pricing pressures but also encourage regional vaccine manufacturing and stronger localized supply chains.

The comprehensive ProQuad market research report provides a detailed analysis, equipping stakeholders with essential statistics, regional market shares, competitor strategies, and market opportunities, ensuring well-informed decisions based on current and future industry scenarios. This valuable resource covers significant regions including Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa, focusing on countries such as the USA, UK, China, and India.

In summary, the ProQuad market is characterized by increasing demand due to outbreaks, sustained government support, and enhanced logistical capabilities, alongside strategic innovations by leading companies addressing emerging market challenges and broadening vaccine accessibility.

Key Topics Covered:

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Proquad Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Proquad Market Attractiveness Scoring and Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment and Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Proquad Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List of Key Raw Materials, Resources & Suppliers

3.3. List of Major Distributors and Channel Partners

3.4. List of Major End Users

4. Global Proquad Market Trends and Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Sustainability, Climate Tech & Circular Economy

4.1.3 Industry 4.0 & Intelligent Manufacturing

4.1.4 Digitalization, Cloud, Big Data and Cybersecurity

4.1.5 Fintech, Blockchain, Regtech & Digital Finance

4.2. Major Trends

4.2.1 Increasing Adoption of Combination Vaccines

4.2.2 Rising Focus on Pediatric Immunization Coverage

4.2.3 Expansion of National Immunization Programs

4.2.4 Growing Emphasis on Cold Chain Optimization

4.2.5 Improved Vaccine Safety and Monitoring Systems

5. Proquad Market Analysis of End Use Industries

5.1 Hospitals

5.2 Pediatric Clinics

5.3 Public Health Organizations

5.4 Vaccination Centers

5.5 Specialty Pharmacies

6. Proquad Market - Macro Economic Scenario Including the Impact of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, and Covid and Recovery on the Market

7. Global Proquad Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis

7.1. Global Proquad PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Proquad Market Size, Comparisons and Growth Rate Analysis

7.3. Global Proquad Historic Market Size and Growth, 2020-2025, Value ($ Billion)

7.4. Global Proquad Forecast Market Size and Growth, 2025-2030, 2035F, Value ($ Billion)

8. Global Proquad Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Proquad Market Segmentation

9.1. Global Proquad Market, Segmentation by Indication, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Measles, Mumps, Rubella, Varicella

9.2. Global Proquad Market, Segmentation by Patient Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Pediatric Patient, Adult Patient

9.3. Global Proquad Market, Segmentation by End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Healthcare Providers, Pharmacies, Public Health Organization

10. Proquad Market Regional and Country Analysis

10.1. Global Proquad Market, Split by Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Proquad Market, Split by Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/bxom31

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.